Clinical characteristics: molecular BL cases
| . | . | . | Path diagnosis . | |||
|---|---|---|---|---|---|---|
| Adult . | Pediatric . | |||||
| . | Adult . | Pediatric . | BL . | DLBCL . | BL . | DLBCL . |
| Current study | ||||||
| Total | 22 | 39 | 18 | 4 | 36 | 3 |
| Male | 14 | 32 | 12 | 2 | 30 | 2 |
| Female | 8 | 7 | 6 | 2 | 6 | 1 |
| Average age (range) | 56.6 (27-82) | 9.2 (3-20) | ||||
| GSE21597 | ||||||
| Total | 9 | 13 | ||||
| Male | 5 | 12 | ||||
| Female | 4 | 1 | ||||
| Average age, y (range) | 41 (24-63) | 7.3 (2-13) | ||||
| Total | 28 | 45 | ||||
| . | . | . | Path diagnosis . | |||
|---|---|---|---|---|---|---|
| Adult . | Pediatric . | |||||
| . | Adult . | Pediatric . | BL . | DLBCL . | BL . | DLBCL . |
| Current study | ||||||
| Total | 22 | 39 | 18 | 4 | 36 | 3 |
| Male | 14 | 32 | 12 | 2 | 30 | 2 |
| Female | 8 | 7 | 6 | 2 | 6 | 1 |
| Average age (range) | 56.6 (27-82) | 9.2 (3-20) | ||||
| GSE21597 | ||||||
| Total | 9 | 13 | ||||
| Male | 5 | 12 | ||||
| Female | 4 | 1 | ||||
| Average age, y (range) | 41 (24-63) | 7.3 (2-13) | ||||
| Total | 28 | 45 | ||||